ArticleFrontiers in immunology2026

Targeted release of budesonide modulates key gut microbial abnormalities in immunoglobulin A nephropathy.

Xiaoyi Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.